Charles River Sees 2012 Non-GAAP EPS of $2.60-2.70 vs 2.67 Est

Charles River Laboratories International, Inc. (NYSE: CRL) today provided guidance for 2012 and updated guidance for 2011.

“We believe market conditions have stabilized, and visibility is improving. As a result, we view 2012 as a more stable year in which sales growth begins to strengthen in a range of 1% to 3% on a constant currency basis, and non-GAAP earnings per share increase between 7% and 11%, or in a range of $2.60 to $2.70”